Literature DB >> 20301115

Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?

Peter A Kanetsky1, Saarene Panossian, David E Elder, DuPont Guerry, Michael E Ming, Lynn Schuchter, Timothy R Rebbeck.   

Abstract

BACKGROUND: A study was carried out to describe associations of MC1R variants and melanoma in a US population and to investigate whether genetic risk is modified by pigmentation characteristics and sun exposure measures.
METHODS: Melanoma patients (n = 960) and controls (n = 396) self-reported phenotypic characteristics and sun exposure via structured questionnaire and underwent a skin examination. Logistic regression was used to estimate associations of high- and low-risk MC1R variants and melanoma, overall and within phenotypic and sun exposure strata. A meta-analysis of results from published studies was undertaken.
RESULTS: Carriage of 2 low-risk or any high-risk MC1R variants was associated with increased risk of melanoma (odds ratio [OR], 1.7; 95% confidence interval [CI], 1.0-2.8; and OR, 2.2; 95% CI, 1.5-3.0, respectively). However, risk was stronger in or limited to individuals with protective phenotypes and limited sun exposure, such as those who tanned well after repeated sun exposure (OR, 2.4; 95% CI, 1.6-3.6), had dark hair (OR, 2.4; 95% CI, 1.5-3.6), or had dark eyes (OR, 3.2; 95% CI, 1.8-5.9). We noted this same pattern of increased melanoma risk among persons who did not freckle, tanned after exposure to first strong summer sun, reported little or average recreational or occupational sun exposure, or reported no sun burning events. Meta-analysis of published literature supported these findings.
CONCLUSIONS: These data indicate that MC1R genotypes provide information about melanoma risk in those individuals who would not be identified as high risk based on their phenotypes or exposures alone. (c) 2010 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20301115      PMCID: PMC2864335          DOI: 10.1002/cncr.24994

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  24 in total

1.  A risk prediction tool for melanoma?

Authors:  David C Whiteman; Adèle C Green
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-04       Impact factor: 4.254

2.  Do differences in data reporting contribute to variation in lung cancer survival?

Authors:  Claire A Butler; Graeme P Currie; Wendy J A Anderson
Journal:  J Natl Cancer Inst       Date:  2005-09-21       Impact factor: 13.506

3.  MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.

Authors:  Maria Teresa Landi; Peter A Kanetsky; Shirley Tsang; Bert Gold; David Munroe; Timothy Rebbeck; Jennifer Swoyer; Monica Ter-Minassian; Mohammad Hedayati; Lawrence Grossman; Alisa M Goldstein; Donato Calista; Ruth M Pfeiffer
Journal:  J Natl Cancer Inst       Date:  2005-07-06       Impact factor: 13.506

4.  Risk factors and individual probabilities of melanoma for whites.

Authors:  Eunyoung Cho; Bernard A Rosner; Diane Feskanich; Graham A Colditz
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

5.  Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color.

Authors:  C Kennedy; J ter Huurne; M Berkhout; N Gruis; M Bastiaens; W Bergman; R Willemze; J N Bavinck
Journal:  J Invest Dermatol       Date:  2001-08       Impact factor: 8.551

6.  Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype?

Authors:  Terence Dwyer; James M Stankovich; Leigh Blizzard; Liesel M FitzGerald; Joanne L Dickinson; Anne Reilly; Jan Williamson; Rosie Ashbolt; Marianne Berwick; Michèle M Sale
Journal:  Am J Epidemiol       Date:  2004-05-01       Impact factor: 4.897

7.  Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene.

Authors:  F Ichii-Jones; J T Lear; A H Heagerty; A G Smith; P E Hutchinson; J Osborne; B Bowers; P W Jones; E Davies; W E Ollier; W Thomson; L Yengi; J Bath; A A Fryer; R C Strange
Journal:  J Invest Dermatol       Date:  1998-08       Impact factor: 8.551

Review 8.  The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes.

Authors:  Richard A Sturm; David L Duffy; Neil F Box; Wei Chen; Darren J Smit; Darren L Brown; Jennifer L Stow; J Helen Leonard; Nicholas G Martin
Journal:  Pigment Cell Res       Date:  2003-06

9.  Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach.

Authors:  Peter A Kanetsky; Fan Ge; Derek Najarian; Jennifer Swoyer; Saarene Panossian; Lynn Schuchter; Robin Holmes; DuPont Guerry; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-05       Impact factor: 4.254

10.  Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE).

Authors:  J M Bliss; D Ford; A J Swerdlow; B K Armstrong; M Cristofolini; J M Elwood; A Green; E A Holly; T Mack; R M MacKie
Journal:  Int J Cancer       Date:  1995-08-09       Impact factor: 7.396

View more
  44 in total

1.  MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study.

Authors:  Anne Kricker; Bruce K Armstrong; Chris Goumas; Peter Kanetsky; Richard P Gallagher; Colin B Begg; Robert C Millikan; Terence Dwyer; Stefano Rosso; Loraine D Marrett; Nancy E Thomas; Marianne Berwick
Journal:  Cancer Causes Control       Date:  2010-08-19       Impact factor: 2.506

2.  Practical and analytical aspects of using friend controls in case-control studies: experience from a case-control study of childhood cancer.

Authors:  Greta R Bunin; Saran Vardhanabhuti; Agueda Lin; Greta L Anschuetz; Nandita Mitra
Journal:  Paediatr Perinat Epidemiol       Date:  2011-07-19       Impact factor: 3.980

3.  MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors.

Authors:  Marianne Berwick; Jamie MacArthur; Irene Orlow; Peter Kanetsky; Colin B Begg; Li Luo; Anne Reiner; Ajay Sharma; Bruce K Armstrong; Anne Kricker; Anne E Cust; Loraine D Marrett; Stephen B Gruber; Hoda Anton-Culver; Roberto Zanetti; Stefano Rosso; Richard P Gallagher; Terence Dwyer; Alison Venn; Klaus Busam; Lynn From; Kirsten White; Nancy E Thomas
Journal:  Pigment Cell Melanoma Res       Date:  2014-01-30       Impact factor: 4.693

4.  Recognizing Latinos' range of skin pigment and phototypes to enhance skin cancer prevention.

Authors:  June K Robinson; Frank J Penedo; Jennifer L Hay; Nina G Jablonski
Journal:  Pigment Cell Melanoma Res       Date:  2017-07-04       Impact factor: 4.693

5.  Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Peter A Kanetsky; Klaus J Busam; Anne Kricker; Bruce K Armstrong; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Li Luo; Irene Orlow; Anne S Reiner; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; Eloise A Parrish; Honglin Hao; David C Gibbs; Jill S Frank; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  J Invest Dermatol       Date:  2017-08-24       Impact factor: 8.551

6.  Risk factors for malignant melanoma in white and non-white/non-African American populations: the multiethnic cohort.

Authors:  Sungshim Lani Park; Loïc Le Marchand; Lynne R Wilkens; Laurence N Kolonel; Brian E Henderson; Zuo-Feng Zhang; Veronica Wendy Setiawan
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-13

7.  Indoor tanning and the MC1R genotype: risk prediction for basal cell carcinoma risk in young people.

Authors:  Annette M Molinaro; Leah M Ferrucci; Brenda Cartmel; Erikka Loftfield; David J Leffell; Allen E Bale; Susan T Mayne
Journal:  Am J Epidemiol       Date:  2015-04-08       Impact factor: 4.897

8.  Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial.

Authors:  Jennifer L Hay; Kate Zielaskowski; Kirsten Meyer White; Kimberly Kaphingst; Erika Robers; Dolores Guest; Andrew Sussman; Yvonne Talamantes; Matthew Schwartz; Vivian M Rodríguez; Yuelin Li; Elizabeth Schofield; Jessica Bigney; Keith Hunley; David Buller; Marianne Berwick
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

9.  Relationship of early-onset baldness to prostate cancer in African-American men.

Authors:  Charnita Zeigler-Johnson; Knashawn H Morales; Elaine Spangler; Bao-Li Chang; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-26       Impact factor: 4.254

10.  Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.

Authors:  F Demenais; H Mohamdi; V Chaudru; A M Goldstein; J A Newton Bishop; D T Bishop; P A Kanetsky; N K Hayward; E Gillanders; D E Elder; M F Avril; E Azizi; P van Belle; W Bergman; G Bianchi-Scarrà; B Bressac-de Paillerets; D Calista; C Carrera; J Hansson; M Harland; D Hogg; V Höiom; E A Holland; C Ingvar; M T Landi; J M Lang; R M Mackie; G J Mann; M E Ming; C J Njauw; H Olsson; J Palmer; L Pastorino; S Puig; J Randerson-Moor; M Stark; H Tsao; M A Tucker; P van der Velden; X R Yang; N Gruis
Journal:  J Natl Cancer Inst       Date:  2010-09-28       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.